The trademark application EXKIVITY was filed by Takeda Pharmaceuticals International AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on June 25, 2020, and it was registered by office on October 2, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).